Cover Image
市場調查報告書

印度的糖尿病市場

Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

出版商 IMARC Services Pvt. Ltd. 商品編碼 345916
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的糖尿病市場 Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
出版日期: 2017年04月03日 內容資訊: 英文 51 Pages
簡介

本報告提供印度的糖尿病市場相關調查,糖尿病盛行率和人口統計的特徵,診斷和治療方法,治療藥,其效果和銷售額等檢驗、分析,主要企業簡介和競爭情形等彙整資料。

第1章 序論

第2章 調查手法

第3章 摘要整理

第4章 糖尿病概要

  • 關於糖尿病
  • 診斷、治療方法
  • 糖尿病的併發症

第5章 印度的糖尿病市場成長要素

第6章 印度的糖尿病的流行病學

  • 糖尿病人口和盛行率
  • 糖尿病人口和盛行率:糖尿病的各類型(Type1,2)
  • 糖尿病人口與盛行率:各地區(城市,地方)
  • 糖尿病人口和盛行率:性別
  • 糖尿病人口和盛行率:各年代
  • 接受糖尿病診斷和藥物治療的患者的比例

第7章 印度的糖尿病市場

  • 過去的市場趨勢
  • 市場明細:各市場區隔
  • 印度的口服血糖投下藥市場
    • 市場趨勢
    • 市場明細:各藥物等級
    • 主要企業的市場佔有率
    • 市場展望
  • 今後的市場展望

第8章 印度的糖尿病診斷市場

  • 市場趨勢
  • 市場區隔
  • 主要企業的市場佔有率
  • 市場展望

第9章 SWOT分析

  • 強味
  • 弱味
  • 機會
  • 威脅

第10章 價值鏈分析

第11章 波特的五力分析

第12章 競爭結構

第13章 主要企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SRP00116IJ

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India's struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC's new report ‘"Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics"’ provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in India
  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
  • Historical, current and future prevalence of diabetes among males and females in India
  • Historical, current and future prevalence of diabetes among various age groups in India
  • Historical, current and future diagnosis rates for diabetes in India
  • Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Diabetes Disease Overview

  • 4.1. What is Diabetes?
  • 4.2. Diabetes Diagnosis and Treatment
    • 4.2.1. Diagnosis
    • 4.2.2. Treatment
  • 4.3. Diabetes Complications

5. Factors Driving the Diabetes Market in India

  • 5.1. Increasing Obesity Levels
  • 5.2. Urbanization
  • 5.3. India has the Second Largest Diabetes Patient Base in the World
  • 5.4. India Represents One of the Fastest Growing Markets Globally
  • 5.5. Improving Diagnosis and Treatment Rates

6. The Indian Diabetes Epidemiology

  • 6.1. Diabetes Population and Prevalence Rates
  • 6.2. Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3. Population and Prevalence Rates by Region (Urban and Rural)
  • 6.4. Population and Prevalence Rates by Gender
  • 6.5. Population and Prevalence Rates by Age Group
  • 6.6. Diabetes Diagnosis and Drug Treatment Rates

7. Indian Diabetes Market

  • 7.1. Historical Market Trends (2009-2016)
  • 7.2. Market Breakup by Segment (2009-2016)
  • 7.3. The Indian Oral Antidiabetics Market
    • 7.3.1. Historical Market Trends (2009-2016)
    • 7.3.2. Market Breakup by Class (2009-2016)
    • 7.3.3. Market Shares of Key Players
    • 7.3.4. Market Outlook (2017-2021)
  • 7.4. The Indian Insulin Market
    • 7.4.1. Historical Market Trends (2017-2021)
    • 7.4.2. Market Breakup by Class
    • 7.4.3. Market Shares of Key Players
    • 7.4.4. Market Outlook (2017-2021)
  • 7.5. Market Outlook (2017-2021)

8. Indian Diabetes Diagnostics Market

  • 8.1. Historical Market Trends (2009-2016)
  • 8.2. Market Segmentation
  • 8.3. Market Shares of Key Players
  • 8.4. Market Outlook (2017-2021)

9. SWOT Analysis

  • 9.1. Strengths
  • 9.2. Weaknesses
  • 9.3. Opportunities
  • 9.4. Threats

10. Value Chain Analysis

11. Porter's Five Forces

12. Competitive Structure

13. Key Player Profiles

  • 13.1. Abbott
  • 13.2. Sanofi
  • 13.3. Eli Lilly
  • 13.4. USV
  • 13.5. Sun Pharma

List of Figures

  • Figure 4-1: The Impact of Diabetes on the Human Body
  • Figure 4-2: Diabetes Complications
  • Figure 4-3: India: Overweight & Obese Population (in Millions), 2009, 2016 & 2021
  • Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes
  • Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2016 & 2021
  • Figure 6-1: India: Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2017-2021
  • Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2009-2016
  • Figure 6-10: India: Total Number of Diabetes Patients by Age Group Forecast (20-39), (40-59) & (60-79) (in Millions), 2017-2021
  • Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2009-2016
  • Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Millions), 2017-2021
  • Figure 7-1: India: Diabetes Market (in Million US$), 2009-2016
  • Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2009-2016
  • Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2009-2016
  • Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009-2016
  • Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
  • Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2017-2021
  • Figure 7-7: India: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2016 & 2020
  • Figure 7-8: India: Insulin Market (in Million US$), 2009-2016
  • Figure 7-9: India: Insulin Market: Sales Share of Key Classes (in %), 2016
  • Figure 7-10: India: Insulin Market: Sales Share of Key Players (in %)
  • Figure 7-11: India: Insulin Market Forecast (in Million US$), 2017-2021
  • Figure 7-12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2016 & 2021
  • Figure 7-13: India: Diabetes Market Forecast (in Million US$), 2017-2021
  • Figure 7-14: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2017-2021
  • Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2009-2016
  • Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %),
  • Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
  • Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2017-2021
  • Figure 9-1: Indian: Diabetes Market: SWOT Analysis
  • Figure 10-1: Indian: Diabetes Market: Value Chain Analysis
  • Figure 11-1: Indian: Diabetes Market: Porter's Five Forces Analysis

List of Tables

  • Table 2-1: India: Diabetes Epidemiology: Executive Summary
  • Table 2-2: India: Diabetes Market: Executive Summary
  • Table 3-1: Diagnosis of Diabetes
  • Table 4-1: India: Overweight & Obesity Statistics, 2005, 2010 & 2016
  • Table 4-2: India: Urban & Rural Population Breakup (in Millions), 1992, 2001, 2011
  • Table 4-3: Global: Diabetes Population Breakup by Country (in 000's), 2016 & 2021
  • Table 4-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
  • Table 5-1: India: Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2021
  • Table 5-6: India: Total Diagnosed & Drug Treated Diabetes Population, 2009, 2016 & 2021
Back to Top